Gvoke HypoPen 0.5 mg Auto-Injector glucagon injection, solution

Get an overview of GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (glucagon injection, solution injection, solution), including its generic name, formulation (i.e. pill, oral solution, injection, inhaled medicine) and why it’s used. The medication in Gvoke HypoPen 0.5 mg Auto-Injector can be sold under different names.

Refer to the “Also Known As” section to reference different products that include the same medication as Gvoke HypoPen 0.5 mg Auto-Injector.

Drug Basics

Brand Name: Gvoke HypoPen 0.5 mg Auto-Injector

Generic Name: GLUCAGON INJECTION, SOLUTION

Drug Type: HUMAN PRESCRIPTION DRUG

Route: SUBCUTANEOUS

Dosage Form: INJECTION, SOLUTION

Packager: Xeris Pharmaceuticals, Inc.

Data Current As Of: 2021-10-18

GVOKE is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above.

GVOKE is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. ( 1)

GVOKE® is a trademark of Xeris Pharmaceuticals, Inc.

Manufactured for Xeris Pharmaceuticals, Inc. by Pyramid Laboratories Inc., Costa Mesa, CA 92626

For information contact:

Xeris Pharmaceuticals, Inc.

180 North LaSalle Street, Suite 1600, Chicago, IL 60601

1-877-XERIS-37 (1-877-937-4737)

www.xerispharma.com

© 2021 Xeris Pharmaceuticals

also known as

This drug label information is as submitted to the Food and Drug Administration (FDA) and is intended for informational purposes only. If you think you may have a medical emergency, immediately call your doctor or dial 911. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Search Drugs and Medication

Or Browse by Name